Trial Profile
Fyn Kinase Inhibitors and Alcohol Drinking
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 Nov 2020
Price :
$35
*
At a glance
- Drugs Saracatinib (Primary)
- Indications Alcoholism
- Focus Therapeutic Use
- 08 Jul 2019 Status changed from recruiting to completed.
- 24 May 2017 Status changed from not yet recruiting to recruiting.
- 09 Nov 2016 New trial record